Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage
Now that it has been
established that the novel coronavirus is going to globally impact the drug
s
Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016
This week, PharmaCompass
reviews the recently released data on prescription drugs paid for under th
J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative
This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk
Teva may get foreign CEO; FDA warns drug makers to check water systems
This week, Phispers brings you an update on Teva’s continuing woes that include fines, plant c
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He
China shuts plants of major antibiotic producers to fight pollution; more troubles for Teva
This week, Phispers has lots on generics. While the global leader Teva has more troubles at hand, ge
Mylan’s EpiPen price hike defense; India throws out plans of a bulk drug policy
This week, Phispers takes you through the EpiPen price hike controversy, and the Indian government&r
Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs
With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch
